Trial Profile
A randomized phase II study of three fludarbine/antibody combinations for patients with symptomatic previously untreated chronic lymphocytic leukemia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Oct 2007
Price :
$35
*
At a glance
- Drugs Fludarabine (Primary) ; Antibodies
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 04 Oct 2007 New trial record.